Source: SEC

Vaxess received $8.4M in Equity Funding

Read full article »

Vaxess's Competitors | Vaxess's News | Vaxess's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

CEO

Rachel Sha

CEO Approval Rating

66/100

Vaxess is a Massachusetts-based life sciences company that designs, develops and supplies shelf-stable MIMIX skin patches for the pharmaceutical industry.